Tharimmune Announces Board and Executive Changes
Ticker: CNTN · Form: 8-K · Filed: Jun 24, 2025 · CIK: 1861657
| Field | Detail |
|---|---|
| Company | Tharimmune, INC. (CNTN) |
| Form Type | 8-K |
| Filed Date | Jun 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation
TL;DR
Tharimmune shakes up its board and exec pay structure.
AI Summary
Tharimmune, Inc. announced on June 22, 2025, changes related to its board of directors and executive compensation. Specifically, the company reported the departure of certain officers and directors, the election of new directors, and adjustments to compensatory arrangements for its officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial priorities.
Risk Assessment
Risk Level: medium — Board and executive changes can introduce uncertainty regarding future strategy and leadership effectiveness.
Key Players & Entities
- Tharimmune, Inc. (company) — Registrant
- June 22, 2025 (date) — Date of earliest event reported
FAQ
Who are the specific directors or officers who have departed from Tharimmune, Inc.?
The filing indicates the departure of certain officers and directors but does not name them specifically in the provided text.
When were the new directors elected to the board of Tharimmune, Inc.?
The filing states that directors were elected as of June 22, 2025, but does not provide specific election dates.
What specific changes were made to the compensatory arrangements of certain officers?
The filing mentions adjustments to compensatory arrangements but does not detail the specifics of these changes in the provided text.
What is the primary business of Tharimmune, Inc.?
Tharimmune, Inc. is in the business of Pharmaceutical Preparations, with SIC code 2834.
What is the principal executive office address for Tharimmune, Inc.?
The principal executive offices are located at 34 Shrewsbury Avenue, Red Bank, NJ 07701.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 regarding Tharimmune, Inc. (CNTN).